Refractory IgG Warm Autoimmune Hemolytic Anemia Treated with Eculizumab: A Novel Application of Anticomplement Therapy

Warm autoimmune hemolytic anemia (wAIHA) is the most common form of AIHA, with corticosteroids in first-line treatment resulting in a 60–80% response rate. Atypical wAIHA and IgG plus complement mediated disease have a higher treatment failure rate and higher recurrence rate. We report a case of sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Kim, Caplan, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820603/
https://www.ncbi.nlm.nih.gov/pubmed/27092282
http://dx.doi.org/10.1155/2016/9181698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820603/
https://www.ncbi.nlm.nih.gov/pubmed/27092282
http://dx.doi.org/10.1155/2016/9181698

Ejemplares similares